These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18056440)

  • 21. Telomere instability in a human tumor cell line expressing NBS1 with mutations at sites phosphorylated by ATM.
    Bai Y; Murnane JP
    Mol Cancer Res; 2003 Dec; 1(14):1058-69. PubMed ID: 14707289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
    Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
    Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
    Zhang ZZ; Liu YJ; Yin XL; Zhan P; Gu Y; Ni XZ
    World J Gastroenterol; 2013 Mar; 19(12):1968-74. PubMed ID: 23569343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites.
    Xu C; Wu L; Cui G; Botuyan MV; Chen J; Mer G
    J Mol Biol; 2008 Aug; 381(2):361-72. PubMed ID: 18582474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
    Allen-Brady K; Camp NJ
    BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer risks and mortality in heterozygous ATM mutation carriers.
    Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
    J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Closing the gaps among a web of DNA repair disorders.
    Michelson RJ; Weinert T
    Bioessays; 2000 Nov; 22(11):966-9. PubMed ID: 11056472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.
    Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W
    Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
    Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
    Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDC1 is required for the intra-S-phase DNA damage checkpoint.
    Goldberg M; Stucki M; Falck J; D'Amours D; Rahman D; Pappin D; Bartek J; Jackson SP
    Nature; 2003 Feb; 421(6926):952-6. PubMed ID: 12607003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nbs1 moving up in the world.
    Stavridi ES; Halazonetis TD
    Nat Cell Biol; 2005 Jul; 7(7):648-50. PubMed ID: 15990895
    [No Abstract]   [Full Text] [Related]  

  • 35. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients.
    Distel LV; Neubauer S; Keller U; Sprung CN; Sauer R; Grabenbauer GG
    Radiother Oncol; 2006 Dec; 81(3):257-63. PubMed ID: 17113667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.
    Lavin MF
    Oncogene; 2007 Dec; 26(56):7749-58. PubMed ID: 18066087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
    Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
    Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin.
    Melander F; Bekker-Jensen S; Falck J; Bartek J; Mailand N; Lukas J
    J Cell Biol; 2008 Apr; 181(2):213-26. PubMed ID: 18411307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
    Cariveau MJ; Tang X; Cui XL; Xu B
    Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.